Luxa’s stem cell therapy for dry AMD shows early promisenews2025-03-06T15:30:04+00:00March 6th, 2025|Endpoints News|
Regeneron, two Chinese biotechs tout promise of their hearing loss gene therapiesnews2025-02-26T16:30:13+00:00February 26th, 2025|Endpoints News|
Deerfield sues Alcon over alleged scheme to obstruct Aurion’s IPOnews2025-02-24T21:02:34+00:00February 24th, 2025|Endpoints News|
Bluebird bio to sell to investment funds after struggling to make money from gene therapiesnews2025-02-21T16:34:08+00:00February 21st, 2025|Endpoints News|
Pfizer ends rollout of Beqvez, putting another dent in hemophilia gene therapy fieldnews2025-02-21T12:24:53+00:00February 21st, 2025|Endpoints News|
Biotech is still trying to make CRISPR a successnews2025-02-19T15:00:35+00:00February 19th, 2025|Endpoints News|
Thermo Fisher to lay off 300 workers at two viral vector factories news2025-02-03T16:17:10+00:00February 3rd, 2025|Endpoints News|
Cargo Therapeutics cuts lead CAR-T program, 50% of staffnews2025-01-30T16:04:27+00:00January 30th, 2025|Endpoints News|
Judge allows Aurion Biotech’s path to IPO despite Alcon objectionsnews2025-01-29T09:35:39+00:00January 29th, 2025|Endpoints News|
Cell therapy biotech Affini-T Therapeutics appears to cut staffnews2025-01-27T20:53:02+00:00January 27th, 2025|Endpoints News|
